Establishment of a Patient-Derived Xenograft of Canine Enteropathy-Associated T-Cell Lymphoma, Large Cell Type. Issue 1 (January 2017)

• Record Type: Journal Article
• Authors: Im, K.S.; Kim, J.H.; Graef, A.J.; Cornax, I.; Seelig, D.M.; O'Sullivan, M.G.; Kovi, R.C.; Modiano, J.F.
• Is Part Of: Journal of comparative pathology. Volume 156:Issue 1(2017)
• Page Start: 37
• Page End: 41
• Publication Date: 2017-01
• Subjects: dog -- enteropathy-associated T-cell lymphoma -- immunodeficient mouse model -- patient-derived tumour xenograft; Veterinary pathology -- Periodicals; Veterinary therapeutics -- Periodicals; Pathology, Comparative -- Periodicals; Therapeutics -- Periodicals; Pathology, Veterinary -- Periodicals; 636.089607
• DOI: 10.1016/j.jcpa.2016.11.271
• Languages: English
• ISSNs: 0021-9975

Abstract

Summary: The pathogenesis of canine T-cell lymphoma remains incompletely understood, partly because there are no well-established in-vivo models to study these malignancies. For this study, we generated a patient-derived tumour xenograft (PDTX) from a 10-year-old neutered male golden retriever dog with enteropathy-associated intestinal T-cell lymphoma, large cell type. One of two female, 15-week-old beige/nude/XID mice developed a visible tumour 7 weeks after sections of tumour material from the spleen were surgically implanted. The histological appearance, immunophenotype and clonal antigen receptor rearrangements of the tumour from the recipient mouse showed that it was derived from the primary canine tumour. Our results indicate that immunodeficient mice are receptive hosts to develop in-vivo PDTX models to study the pathogenesis and management of canine T-cell lymphomas.